• LAST PRICE
    3.3200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 3.3200
  • Day Range
    ---
  • 52 Week Range
    Low 1.6200
    High 24.7100
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.23
TimeVolumeVTGN
09:32 ET24463.23
09:41 ET4183.305
09:43 ET1003.28
09:48 ET1003.28
09:50 ET10003.2897
09:54 ET3003.28
09:59 ET46203.3
10:01 ET9003.3
10:03 ET8003.32
10:06 ET23003.31
10:12 ET36903.33
10:14 ET6593.34
10:17 ET1003.358
10:19 ET19963.3101
10:21 ET1003.33
10:28 ET27833.36
10:30 ET11293.36
10:32 ET2903.37
10:33 ET95203.335
10:39 ET2003.35
10:44 ET1003.35
10:48 ET2003.3595
10:51 ET1003.36
10:55 ET2003.36
11:02 ET22023.37
11:06 ET5003.37
11:11 ET4003.3791
11:18 ET3903.38
11:24 ET1003.37
11:26 ET1003.37
11:29 ET7603.36
11:42 ET1003.345
11:45 ET1003.345
11:56 ET1003.3541
11:58 ET6003.34
12:03 ET1003.34
12:05 ET3003.31
12:09 ET1133.3112
12:16 ET8003.33
12:20 ET1053.32
12:27 ET29103.33
12:30 ET5533.34
12:34 ET4003.34
12:36 ET1003.335
12:38 ET1003.335
12:43 ET1003.335
12:54 ET1053.335
12:59 ET10003.335
01:01 ET10003.3499
01:06 ET3003.35
01:21 ET3003.36
01:24 ET1003.36
01:26 ET1003.355
01:35 ET1003.35
01:37 ET6613.37
01:39 ET7003.37
01:48 ET1003.365
01:50 ET2003.36
01:53 ET10003.3473
02:13 ET1003.36
02:15 ET6303.36
02:22 ET1003.37
02:29 ET1323.38
02:31 ET1003.39
02:33 ET1003.385
02:51 ET8003.34
02:54 ET1003.33
03:03 ET2093.34
03:09 ET1003.335
03:18 ET1003.33
03:23 ET4753.3402
03:25 ET1003.345
03:30 ET6753.34
03:32 ET1003.33
03:34 ET2003.33
03:36 ET5003.32
03:38 ET1753.33
03:39 ET128823.3
03:41 ET4253.3138
03:43 ET2003.31
03:45 ET6003.32
03:48 ET1003.33
03:50 ET2003.338
03:52 ET3153.338
03:54 ET2003.33
03:56 ET4003.33
03:57 ET2003.33
03:59 ET5003.32
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTGN
Vistagen Therapeutics Inc
89.7M
-1.6x
---
United StatesORMP
Oramed Pharmaceuticals Inc
91.0M
9.0x
---
United StatesRLMD
Relmada Therapeutics Inc
90.2M
-1.0x
---
United StatesALVR
Allovir Inc
88.8M
-0.5x
---
United StatesCDT
Conduit Pharmaceuticals Inc
90.8M
-36.3x
---
United StatesELDN
Eledon Pharmaceuticals Inc
91.6M
-1.7x
---
As of 2024-06-26

Company Information

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company focuses on transforming the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. It is advancing therapeutics for treatment of anxiety, depression, and multiple CNS disorders. Its pipeline includes six clinical-stage product candidates, including fasedienol (PH94B), itruvone (PH10), PH15, PH80, and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral antagonist of the N-methyl-D-aspartate receptor (NMDAR). Pherines, which are administered as low-dose nasal sprays, are designed with a rapid-onset mechanism of action that activates chemosensory neurons in the nasal cavity and can impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons in the brain. PH94B is a synthetic investigational pherine from the androstane family.

Contact Information

Headquarters
343 ALLERTON AVENUESOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-577-3600
Fax
---

Executives

Independent Chairman of the Board
Margaret Fitzpatrick
Chief Executive Officer, Director
Shawn Singh
Chief Financial Officer
Cynthia Anderson
Chief Operating Officer
Joshua Prince
Senior Vice President - Investor Relations
Mark Mcpartland

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$87.3M
Revenue (TTM)
$1.1M
Shares Outstanding
27.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.74
EPS
$-2.12
Book Value
$4.23
P/E Ratio
-1.6x
Price/Sales (TTM)
82.0
Price/Cash Flow (TTM)
---
Operating Margin
-3,103.48%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.